who invented tirzepatide FDA approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an estimated price Episode 153. All About Zepbound
Pay in 4 interest-free payments of $5.05 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Live Spec
Episode 153. All About Zepbound (Tirzepatide) In today's episode, I'm diving into everything you need to know about Zepbound (tirzepatide) the newest obesity medication now available in Canada. I'll explain how Semaglutide and tirzepatide are both injectable medications used in medical weight managementbut they act on different metabolic pathways, which is why patient selection matters. Semaglutide (GLP 1 receptor agonist): Primarily targets appetite Understanding Tirzepatide: The Dual Action Breakthrough What Exactly Is It? Tirzepatide is a medication used to manage Type 2 diabetes and chronic weight management. It is the first in a class of drugs Semaglutide vs Tirzepatide, same medication class, different receptor targets. Here's what that actually means. Semaglutide targets the GLP 1 receptor, found in the brain, gut, and pancreas. Tirzepatide targets two: GLP 1 and GIP. Tirzepatide C225H348N48O68 CID 156588324 PubChem Mounjaro (tirzepatide) for the Treatment of Type 2 Diabetes, USA
Store: tnailspamo.com · Domain: tnailspamo.com















![Mechanism of action of GLP-1 [25]](https://www.researchgate.net/publication/256289222/figure/fig1/AS:614177232142337@1523442671231/Mechanism-of-action-of-GLP-1-25.png)






